Company news
Hikma Pharmaceuticals PLC news in 2026
Hikma Pharmaceuticals PLC's news releases, calls and decks from 2026, newest first.
Hikma Pharmaceuticals confirms full year 2026 Group guidance
November 5, 2026
Trading Statement
November 5, 2026
Holding(s) in Company
October 21, 2026
Holding(s) in Company
October 20, 2026
Hikma appoints Rebecca Hall as CFO
September 24, 2026
Hikma R&D Investor Spotlight Series
September 22, 2026
Hikma Pharmaceuticals advances its epinephrine nasal spray with multi-market regulatory filings
September 9, 2026
Hikma Pharmaceuticals advances climate progress with first solar energy agreement
August 11, 2026
Directorate change
August 6, 2026
Half-year Financial Report
August 6, 2026
Hikma Pharmaceuticals welcomes FDA approval of Guardant360® Liquid CDx
June 22, 2026
Hikma comments on Supreme Court of the United States' unanimous decision in favour of Hikma
June 4, 2026
Hikma Pharmaceuticals Announces Major Expansion in Ohio, Creating 350 New Jobs and Investing $267 Million
June 1, 2026
Hikma Pharmaceuticals and Marius Pharmaceuticals announce licensing agreement for KYZATREX® (testosterone undecanoate) C...
May 5, 2026
Hikma Pharmaceuticals announces settlement agreement for VYNDAMAX® (tafamidis)
April 28, 2026
Hikma Pharmaceuticals reiterates full year 2026 guidance following encouraging start to the year
April 23, 2026
Transaction in Own Shares
March 23, 2026
Annual Financial Report and Notice of AGM
March 18, 2026
Director/PDMR Shareholding
March 11, 2026
Total Voting Rights
March 2, 2026
Launch of Buyback Programme
February 26, 2026
Final Results, Share Buyback & Leadership Changes
February 26, 2026
Hikma Pharmaceuticals launches authorised generic of Nucynta® (tapentadol) in the US
February 25, 2026
Statement regarding Hikma Pharmaceuticals Plc
February 4, 2026
Notice of Results
February 3, 2026
Par Health Names Dr. William Larkins as EVP and Chief Scientific Officer and President, Sterile Injectables
January 12, 2026
Calls in 2026
Decks in 2026
- H1 2026 Earnings Presentation
Earnings · 23 slides · Aug 6, 2026
- FY2025 Earnings Presentation
Earnings · 30 slides · Feb 26, 2026